载阿霉素自组装多肽水凝胶的制备及体外评价(5)
[3]牛晓辉.骨肉瘤治疗的历史、现状和未来[J].骨科临床与研究杂志,2019,4(5):257-260.
[4]DAHLIN DC, COVENTRY MB. Osteogenic sarcoma. A study of six hundred cases. J Bone Joint Surg Am. 1967;49(1):101-110.
[5]MARCOVE RC, MIKE V, HAJEK JV, et al. Osteogenic sarcoma under the age of Twenty-one: review of one hundred and forty-five operative cases. J Bone Joint Surg Am. 1970;52(3):411-423.
[6]GIANFERANTE DM, MIRABELLO L, SAVAGE SA. Germline and somatic genetics of osteosarcoma-connecting aetiology biology and therapy. Nat Rev Endocrinol. 2017;13(8):480-491.
[7]HARRISON DJ, GELLER DS, GILL JD, et al. Current and future therapeutic approaches for osteosarcoma. Expert Rev Anticancer. 2017;18(1):39-50.
[8]ZHANG B, SHAN Y, CHEN K. A facile approach to fabricate of photothermal functional Fe3O4@CuS microspheres. Mater Chem Phys. 2017;193:82-88.
[9]HATTINGER CM, FANELLI M, TAVANTI E, et al. Advances in emerging drugs for osteosarcoma. Expert Opin Emerg Dr. 2015;20(3):495-514.
[10]SMORENBURG CH, DE GROOT SM, VAN LEEUWEN-STOK AE, et al. A randomized phase III study comparing pegylated liposomal doxorubicin with capecitabine as first-line chemotherapy in elderly patients with metastatic breast cancer: results of the OMEGA study of the Dutch Breast Cancer Research Group BOOG. Ann oncol. 2014;25(3):599-605.
[11]ALHOWAIL AH, BLOEMER J, MAJRASHI M, et al. Doxorubicin-induced neurotoxicity is associated with acute alterations in synaptic plasticity,apoptosis, and lipid peroxidation. Toxicol Mech Method. 2019;29(6):457-466.
[12]VEJPONGSA P, YEH ETH. Prevention of anthracycline-induced cardiotoxicity:challenges and opportunities. J Am Coll Cardiol. 2014;64(9):938-945.
[13]HAGHIRALSADAT F, AMOABEDINY G, SHEIKHHA MH, et al. New liposomal doxorubicin nanoformulation for osteosarcoma: Drug release kinetic study based on thermo and pH sensitivity. Chem Biol Drug Des. 2017;90(3):368-379.
[14]JONKER AM, L?WIK DWPM , VAN HEST JCM. Peptide- and Protein-Based Hydrogels. Chem Mater. 2012;24(5):759-773.
[15]TAO H, WU Y, LI H, et al. BMP7-Based Functionalized Self-Assembling Peptides for Nucleus Pulposus Tissue Engineering. ACS Appl Mater ;7(31):-.
[16]SARKAR B, NGUYEN PK, GAO W, et al. Angiogenic Self-Assembling Peptide Scaffolds for Functional Tissue Regeneration. Biomacromolecules. 2018;19(9):3597-3611.
[17]KARAVASILI C, ANDREADIS DA, KATSAMENIS OL, et al. Synergistic Antitumor Potency of a Self-Assembling Peptide Hydrogel for the Local Co-delivery of Doxorubicin and Curcumin in the Treatment of Head and Neck Cancer. Mol Pharmaceutic. 2019;16(6):2326-2341.
[18]PHIPPS MC, MONTE F, MEHTA M, et al. Intraosseous Delivery of Bone Morphogenic Protein-2 Using a Self-Assembling Peptide 2016;17(7):2329-2336.
[19]KARAVASILI C, KOMNENOU A, KATSAMENIS OL, et al. Self-Assembling Peptide Nanofiber Hydrogels for Controlled Ocular Delivery of Timolol Maleate. ACS Biomater Sci Eng. 2017;3(12):3386-3394.
[20]DAO HM, CHEN J, TUCKER BS, et al. Hemopressin-Based pH-Sensitive Hydrogel: A Potential Bioactive Platform for Drug Delivery. ACS Biomater Sci Eng. 2018;4(7):2435-2442.
[21]WANG Y, CUI M, JIAO M, et al. Antifouling and ultrasensitive biosensing interface based on self-assembled peptide and aptamer on macroporous gold for electrochemical detection of immunoglobulin E in serum. Anal Bioanal Chem. 2018;410(23):5871-5878.
[22]LOWIK DW, LEUNISSEN EH, VAN DEN HEUVEL M, et al. Stimulus responsive peptide based materials. Chem Soc Rev. 2010;39(9):3394-3412.
[23]CUI M, WANG Y, JIAO M, et al. Mixed Self-Assembled Aptamer and Newly Designed Zwitterionic Peptide as Antifouling Biosensing Interface for Electrochemical Detection of alpha-Fetoprotein. ACS Sens. 2017;2(4): 490-494.
[24]LI L, LI JY, GUO JM, et al. 3D Molecularly Functionalized Cell-Free Biomimetic Scaffolds for Osteochondral Regeneration. Adv Funct Mater. 2018;29(6):.1-.12.
[25]FREEMAN R, BOEKHOVEN J, DICKERSON MB, et al. Biopolymers and supramolecular polymers as biomaterials for biomedicals for biomedical applications. MRS Bull. 2015;40(12):1089-1101.
[26]SENAPATI S, MAHANTA AK, KUMAR S, et al. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Tar. 2018; 3(1):7.
[27]KARAVASILI C, PANTERIS E, VIZIRIANAKIS IS, et al. Chemotherapeutic Delivery from a Self-Assembling Peptide Nanofiber Hydrogel for the Management of Glioblastoma. Pharm Res. 2018;35(8):166.
[28]XU X, CHEN C, CHEN J. Molecular self-assembly of peptide. SCIENTIA SINICA Chimica. 2011;41(2):221-238.
[29]TANG C, MILLER AF, SAIANI A. Peptide hydrogels as mucoadhesives for local drug delivery. Int J Pharm. 2014;465(1-2):427-435.
[30]BOOTHROYD S, SAIANI A, MILLER AF. Controlling network topology and mechanical properties of co-assembling peptide hydrogels. ;101(6):669-680.
[31]WAN S, BORLAND S, RICHARDSON SM, et al. Self-assembling peptide hydrogel for intervertebral disc tissue engineering. Acta Biomater. 2016;46:29-40.
文章来源:《中国肿瘤生物治疗杂志》 网址: http://www.zgzlswzlzz.cn/qikandaodu/2021/0524/622.html
上一篇:分析在口腔颌面部肿瘤术后患者整体护理措施及
下一篇:没有了